| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |